These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16788767)

  • 21. Cannabinoid receptor 1 gene and irritable bowel syndrome: phenotype and quantitative traits.
    Camilleri M; Kolar GJ; Vazquez-Roque MI; Carlson P; Burton DD; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2013 Mar; 304(5):G553-60. PubMed ID: 23306084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoid receptor 1 gene is associated with alcohol dependence.
    Marcos M; Pastor I; de la Calle C; Barrio-Real L; Laso FJ; González-Sarmiento R
    Alcohol Clin Exp Res; 2012 Feb; 36(2):267-71. PubMed ID: 22085192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential.
    Stadelmann AM; Juckel G; Arning L; Gallinat J; Epplen JT; Roser P
    Neurosci Lett; 2011 May; 496(1):60-4. PubMed ID: 21513772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1).
    Barrero FJ; Ampuero I; Morales B; Vives F; de Dios Luna Del Castillo J; Hoenicka J; García Yébenes J
    Pharmacogenomics J; 2005; 5(2):135-41. PubMed ID: 15668727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between the T102C polymorphism of the serotonin-2A receptor gene and schizophrenia.
    Vaquero Lorenzo C; Baca-Garcia E; Diaz-Hernandez M; Botillo-Martin C; Perez-Rodriguez MM; Fernandez-Ramos C; Saiz-Gonzalez MD; Quintero-Gutierrez FJ; Saiz-Ruiz J; Fernandez Piqueras J; Gonzalez de Rivera JL; de Leon J
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1136-8. PubMed ID: 16762472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia.
    Ujike H; Morita Y
    J Pharmacol Sci; 2004 Dec; 96(4):376-81. PubMed ID: 15613777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The G1359A-CNR1 gene polymorphism is associated to glioma in Spanish patients.
    Núñez M; Perdomo S; Moreta J; Santos-Briz Á; González-Sarmiento R
    Clin Transl Oncol; 2010 Dec; 12(12):825-8. PubMed ID: 21156413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tourette syndrome is not caused by mutations in the central cannabinoid receptor (CNR1) gene.
    Gadzicki D; Müller-Vahl KR; Heller D; Ossege S; Nöthen MM; Hebebrand J; Stuhrmann M
    Am J Med Genet B Neuropsychiatr Genet; 2004 May; 127B(1):97-103. PubMed ID: 15108190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between schizophrenia and a microsatellite polymorphism at the dopamine D5 receptor gene.
    Williams NM; Cardno AG; Murphy KC; Jones LA; Asherson P; McGuffin P; Owen MJ
    Psychiatr Genet; 1997; 7(2):83-5. PubMed ID: 9285966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the polymorphic (GT)(n) repeat at the dopamine beta-hydroxylase gene in Spanish patients affected by schizophrenia.
    Arrufat FJ; Diaz R; Queralt R; Navarro V; Marcos T; Massana G; Massana J; Ballesta F; Oliva R
    Am J Med Genet; 2000 Feb; 96(1):88-92. PubMed ID: 10686559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between single nucleotide polymorphisms in the cannabinoid receptor gene (CNR1) and impulsivity in southwest California Indians.
    Ehlers CL; Slutske WS; Lind PA; Wilhelmsen KC
    Twin Res Hum Genet; 2007 Dec; 10(6):805-11. PubMed ID: 18179391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis.
    Rossi S; Bozzali M; Bari M; Mori F; Studer V; Motta C; Buttari F; Cercignani M; Gravina P; Mastrangelo N; Castelli M; Mancino R; Nucci C; Sottile F; Bernardini S; Maccarrone M; Centonze D
    PLoS One; 2013; 8(12):e82848. PubMed ID: 24391723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1.
    Proudnikov D; Kroslak T; Sipe JC; Randesi M; Li D; Hamon S; Ho A; Ott J; Kreek MJ
    Pharmacogenomics J; 2010 Jun; 10(3):232-42. PubMed ID: 20010914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CNR1 variation is associated with the age at onset in Huntington disease.
    Kloster E; Saft C; Epplen JT; Arning L
    Eur J Med Genet; 2013 Aug; 56(8):416-9. PubMed ID: 23747361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia.
    Tao R; Li C; Jaffe AE; Shin JH; Deep-Soboslay A; Yamin R; Weinberger DR; Hyde TM; Kleinman JE
    Transl Psychiatry; 2020 May; 10(1):158. PubMed ID: 32433545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Childhood obesity and the role of dopamine D2 receptor and cannabinoid receptor-1 gene polymorphisms.
    Col Araz N; Nacak M; Oguzkan Balci S; Benlier N; Araz M; Pehlivan S; Balat A; Aynacioglu AS
    Genet Test Mol Biomarkers; 2012 Dec; 16(12):1408-12. PubMed ID: 23057570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CNR1 gene and risk of the metabolic syndrome in patients with schizophrenia.
    Yu W; De Hert M; Moons T; Claes SJ; Correll CU; van Winkel R
    J Clin Psychopharmacol; 2013 Apr; 33(2):186-92. PubMed ID: 23422373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of Association between (AAT)n Polymorphism of the
    Machoy-Mokrzyńska A; Rać M; Jurewicz A; Dziedziejko V; Safranow K; Kurzawski M; Boroń A; Stefaniak A; Leźnicka K; Bohatyrewicz A; Białecka M
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the CNR1 gene in schizophrenia: a systematic review including unpublished data.
    Gouvêa ES; Santos AF; Ota VK; Mrad V; Gadelha A; Bressan RA; Cordeiro Q; Belangero SI
    Braz J Psychiatry; 2017; 39(2):160-171. PubMed ID: 28099629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The T393C polymorphism of the GNAS1 gene is associated with deficit schizophrenia in an Italian population sample.
    Minoretti P; Politi P; Coen E; Di Vito C; Bertona M; Bianchi M; Emanuele E
    Neurosci Lett; 2006 Apr 10-17; 397(1-2):159-63. PubMed ID: 16406317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.